Russell Pieper, PhD

Title(s)Professor, Neurological Surgery
SchoolSchool of Medicine
Address1450 Third Street, #492A
San Francisco CA 94158
Phone415-502-7132
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    University of Wisconsin, Madison, WIBS1982Pharmacy
    The George Washington Univeristy, Washington, DCPhD1987Pharmacology

    Collapse Overview 
    Collapse Overview
    Russ Pieper, PhD is a lab-based investigator in the UCSF Brain Tumor Center. He received a BS degree in Pharmacy from the University of Wisconsin and a PhD degree in Pharmacology from The George Washington University in Washington, DC, followed by postdoctoral training and a faculty position at Loyola University-Chicago. He is currently the Neill H. and Linda S. Brownstein Chair in Brain Tumor Research and Professor and Vice-Chairman of the UCSF Department of Neurological Surgery. He is also Director of Basic Research in the UCSF Brain Tumor Research Center and co-Leader of the Neuro-Oncology Program in the Helen Diller Family Comprehensive Cancer Center. His research has been independently funded by the National Institutes of Health and the National Cancer Institute since 1989 and is focused on the role signal transduction plays in the development and therapy of brain tumors. The laboratory is currently focused on how mutant IDH1 expression regulates telomere biology and contributes to the development of lower-grade glioma.

    Collapse Research 
    Collapse Research Activities and Funding
    Contributions of IDH1 mutation to alternative lengthening of telomeres in lower-grade glioma
    NIH R01NS105087Sep 15, 2017 - May 31, 2022
    Role: Principal Investigator
    Understanding the role of altered metabolism in gliomagenesis
    NIH R01CA171610Feb 1, 2013 - Jan 31, 2019
    Role: Principal Investigator
    Training Program in Translational Brain Tumor Research
    NIH T32CA151022Sep 1, 2010 - Aug 31, 2025
    Role: Co-Principal Investigator
    A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM
    NIH R01CA136774Jul 1, 2009 - Apr 30, 2014
    Role: Principal Investigator
    UNDERSTANDING TRAIL SENSITIVITY IN HUMAN GLIOMA
    NIH R01CA115638Jun 1, 2006 - Apr 30, 2012
    Role: Principal Investigator
    Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma
    NIH P01CA118816Dec 1, 2005 - Jul 31, 2024
    Role: Co-Investigator
    P38, G2 Arrest, and Temozolomide Resistance in Gliomas
    NIH R01CA100011Feb 1, 2004 - Jan 31, 2010
    Role: Principal Investigator
    Brain Tumor SPORE Grant
    NIH P50CA097257Sep 20, 2002 - Aug 31, 2023
    Role: Co-Investigator
    Contributions of Akt to Glioblastoma Formation
    NIH R01CA094989Apr 1, 2002 - Mar 31, 2007
    Role: Principal Investigator
    TRIGGERING OF ABERRANT CPG ISLAND METHYLATION
    NIH R01CA085352Jul 1, 2000 - Jun 30, 2003
    Role: Principal Investigator
    EXPRESSION AND SILENCING OF CPG ISLAND-CONTAINING GENES
    NIH R01CA079496Mar 1, 1999 - Feb 28, 2002
    Role: Principal Investigator
    CHROMATIN STRUCTURE AND CONTROL
    NIH R01CA055064Aug 1, 1997 - Jun 30, 2000
    Role: Principal Investigator
    ALKYLTRANSFERASE STRUCTURE AND FUNCTION
    NIH R01CA062389Jul 1, 1994 - Jun 30, 1998
    Role: Principal Investigator
    ALKYLTRANSFERASE EXPRESSION/DNA METHYLATION
    NIH R29CA055064Jul 1, 1991 - Jun 30, 1997
    Role: Principal Investigator
    CONSEQUENCES OF SELECTIVE INDUCTION OF DNA CROSSLINKS
    NIH F32CA008685Sep 22, 1990
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial sections. bioRxiv. 2024 Mar 18. Schupp PG, Shelton SJ, Brody DJ, Eliscu R, Johnson BE, Mazor T, Kelley KW, Potts MB, McDermott MW, Huang EJ, Lim DA, Pieper RO, Berger MS, Costello JF, Phillips JJ, Oldham MC. PMID: 37645893; PMCID: PMC10461981.
      View in: PubMed   Mentions:
    2. Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma. Neuro Oncol. 2022 11 02; 24(11):1898-1910. Minami N, Hong D, Stevers N, Barger CJ, Radoul M, Hong C, Chen L, Kim Y, Batsios G, Gillespie AM, Pieper RO, Costello JF, Viswanath P, Ronen SM. PMID: 35460557; PMCID: PMC9629440.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    3. CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma. Clin Cancer Res. 2022 07 01; 28(13):2898-2910. Kumar A, Mohamed E, Tong S, Chen K, Mukherjee J, Lim Y, Wong CM, Boosalis Z, Shai A, Pieper RO, Gupta N, Perry A, Bollen AW, Molinaro AM, Solomon DA, Shieh JTC, Phillips JJ. PMID: 35511927; PMCID: PMC9250623.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    4. Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomas. Neuro Oncol. 2022 07 01; 24(7):1101-1112. Taglang C, Batsios G, Mukherjee J, Tran M, Gillespie AM, Hong D, Ronen SM, Artee Luchman H, Pieper RO, Viswanath P. PMID: 35091751; PMCID: PMC9248401.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    5. MRE11 and UBR5 Co-Operate to Suppress RNF168-Mediated Fusion of Dysfunctional Telomeres. Front Oncol. 2021; 11:772233. Tang Y, Mukherjee J, Pieper RO. PMID: 34881184; PMCID: PMC8645554.
      View in: PubMed   Mentions: 1  
    6. Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas. Neuro Oncol. 2021 09 01; 23(9):1509-1522. Viswanath P, Batsios G, Ayyappan V, Taglang C, Gillespie AM, Larson PEZ, Luchman HA, Costello JF, Pieper RO, Ronen SM. PMID: 33864084; PMCID: PMC8408874.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    7. RETRACTED: A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells. Sci Transl Med. 2021 05 05; 13(592). Mukherjee J, Pandita A, Kamalakar C, Johannessen TC, Ohba S, Tang Y, Dalle-Ore CL, Bjerkvig R, Pieper RO. PMID: 33952676.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    8. Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in Glioma. Metabolites. 2021 Feb 13; 11(2). Radoul M, Hong D, Gillespie AM, Najac C, Viswanath P, Pieper RO, Costello JF, Luchman HA, Ronen SM. PMID: 33668509; PMCID: PMC7917625.
      View in: PubMed   Mentions: 12  
    9. Non-invasive assessment of telomere maintenance mechanisms in brain tumors. Nat Commun. 2021 01 04; 12(1):92. Viswanath P, Batsios G, Mukherjee J, Gillespie AM, Larson PEZ, Luchman HA, Phillips JJ, Costello JF, Pieper RO, Ronen SM. PMID: 33397920; PMCID: PMC7782549.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    10. Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment. Cancer Res. 2020 11 15; 80(22):5098-5108. Subramani E, Radoul M, Najac C, Batsios G, Molloy AR, Hong D, Gillespie AM, Santos RD, Viswanath P, Costello JF, Pieper RO, Ronen SM. PMID: 32958546; PMCID: PMC7669718.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    11. The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas. Neurosurgery. 2020 08 01; 87(2):408-417. Ohba S, Murayama K, Kuwahara K, Pareira ES, Nakae S, Nishiyama Y, Adachi K, Yamada S, Sasaki H, Yamamoto N, Abe M, Mukherjee J, Hasegawa M, Pieper RO, Hirose Y. PMID: 31833548.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa088. Jones LE, Hilz S, Grimmer MR, Mazor T, Najac C, Mukherjee J, McKinney A, Chow T, Pieper RO, Ronen SM, Chang SM, Phillips JJ, Costello JF. PMID: 32904945; PMCID: PMC7462278.
      View in: PubMed   Mentions: 11  
    13. MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma. Theranostics. 2020; 10(19):8757-8770. Molloy AR, Najac C, Viswanath P, Lakhani A, Subramani E, Batsios G, Radoul M, Gillespie AM, Pieper RO, Ronen SM. PMID: 32754276; PMCID: PMC7392019.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    14. Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity. Cell Rep. 2020 04 14; 31(2):107518. Ohba S, Johannessen TA, Chatla K, Yang X, Pieper RO, Mukherjee J. PMID: 32294440.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    15. PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival. Sci Rep. 2019 07 19; 9(1):10521. Batsios G, Viswanath P, Subramani E, Najac C, Gillespie AM, Santos RD, Molloy AR, Pieper RO, Ronen SM. PMID: 31324855; PMCID: PMC6642106.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    16. Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in Cancer. Cancer Discov. 2019 06; 9(6):756-777. Chen D, Xia S, Wang M, Lin R, Li Y, Mao H, Aguiar M, Famulare CA, Shih AH, Brennan CW, Gao X, Pan Y, Liu S, Fan J, Jin L, Song L, Zhou A, Mukherjee J, Pieper RO, Mishra A, Peng J, Arellano M, Blum WG, Lonial S, Boggon TJ, Levine RL, Chen J. PMID: 30862724; PMCID: PMC6548588.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    17. HDAC inhibition in glioblastoma monitored by hyperpolarized 13 C MRSI. NMR Biomed. 2019 02; 32(2):e4044. Radoul M, Najac C, Viswanath P, Mukherjee J, Kelly M, Gillespie AM, Chaumeil MM, Eriksson P, Delos Santos R, Pieper RO, Ronen SM. PMID: 30561869; PMCID: PMC6545173.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    18. Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro. Sci Rep. 2018 04 11; 8(1):5805. Wood MD, Mukherjee J, Pieper RO. PMID: 29643433; PMCID: PMC5895785.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    19. Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner. Cancer Metab. 2018; 6:3. Viswanath P, Radoul M, Izquierdo-Garcia JL, Luchman HA, Gregory Cairncross J, Pieper RO, Phillips JJ, Ronen SM. PMID: 29619216; PMCID: PMC5881177.
      View in: PubMed   Mentions: 23  
    20. Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma. Cancer Res. 2018 06 01; 78(11):2966-2977. Mukherjee J, Johannessen TC, Ohba S, Chow TT, Jones L, Pandita A, Pieper RO. PMID: 29545335; PMCID: PMC10578296.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    21. 2-Hydroxyglutarate-Mediated Autophagy of the Endoplasmic Reticulum Leads to an Unusual Downregulation of Phospholipid Biosynthesis in Mutant IDH1 Gliomas. Cancer Res. 2018 05 01; 78(9):2290-2304. Viswanath P, Radoul M, Izquierdo-Garcia JL, Ong WQ, Luchman HA, Cairncross JG, Huang B, Pieper RO, Phillips JJ, Ronen SM. PMID: 29358170; PMCID: PMC5932252.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    22. Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process. Cancer Res. 2016 11 15; 76(22):6680-6689. Ohba S, Mukherjee J, Johannessen TC, Mancini A, Chow TT, Wood M, Jones L, Mazor T, Marshall RE, Viswanath P, Walsh KM, Perry A, Bell RJ, Phillips JJ, Costello JF, Ronen SM, Pieper RO. PMID: 27758882; PMCID: PMC5290072.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    23. UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy. Oncogene. 2017 02 23; 36(8):1145-1156. Hu L, Li X, Liu Q, Xu J, Ge H, Wang Z, Wang H, Wang Z, Shi C, Xu X, Huang J, Lin Z, Pieper RO, Weng C. PMID: 27593939.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    24. Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis. Mol Cancer Res. 2016 10; 14(10):976-983. Johannessen TA, Mukherjee J, Viswanath P, Ohba S, Ronen SM, Bjerkvig R, Pieper RO. PMID: 27430238; PMCID: PMC5065766.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    25. Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters. Oncotarget. 2016 Jun 07; 7(23):34942-55. Viswanath P, Najac C, Izquierdo-Garcia JL, Pankov A, Hong C, Eriksson P, Costello JF, Pieper RO, Ronen SM. PMID: 27144334; PMCID: PMC5085201.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    26. PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells. Int J Cancer. 2016 Jul 01; 139(1):99-111. Mukherjee J, Ohba S, See WL, Phillips JJ, Molinaro AM, Pieper RO. PMID: 26874904; PMCID: PMC6615049.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    27. IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism. Cancer Res. 2015 Aug 01; 75(15):2999-3009. Izquierdo-Garcia JL, Viswanath P, Eriksson P, Cai L, Radoul M, Chaumeil MM, Blough M, Luchman HA, Weiss S, Cairncross JG, Phillips JJ, Pieper RO, Ronen SM. PMID: 26045167; PMCID: PMC4526330.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    28. Metabolic reprogramming in mutant IDH1 glioma cells. PLoS One. 2015; 10(2):e0118781. Izquierdo-Garcia JL, Viswanath P, Eriksson P, Chaumeil MM, Pieper RO, Phillips JJ, Ronen SM. PMID: 25706986; PMCID: PMC4338038.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    29. Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells. Cancer Res. 2014 Dec 01; 74(23):7115-24. Park I, Mukherjee J, Ito M, Chaumeil MM, Jalbert LE, Gaensler K, Ronen SM, Nelson SJ, Pieper RO. PMID: 25320009; PMCID: PMC4253720.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    30. Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase. PLoS One. 2014; 9(9):e108289. Izquierdo-Garcia JL, Cai LM, Chaumeil MM, Eriksson P, Robinson AE, Pieper RO, Phillips JJ, Ronen SM. PMID: 25243911; PMCID: PMC4171511.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    31. Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance. Cancer Res. 2014 Sep 01; 74(17):4836-44. Ohba S, Mukherjee J, See WL, Pieper RO. PMID: 25035396; PMCID: PMC4154998.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    32. Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma. Cancer Res. 2014 Aug 15; 74(16):4247-57. Chaumeil MM, Larson PE, Woods SM, Cai L, Eriksson P, Robinson AE, Lupo JM, Vigneron DB, Nelson SJ, Pieper RO, Phillips JJ, Ronen SM. PMID: 24876103; PMCID: PMC4134724.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    33. Lactate dehydrogenase A silencing in IDH mutant gliomas. Neuro Oncol. 2014 May; 16(5):686-95. Chesnelong C, Chaumeil MM, Blough MD, Al-Najjar M, Stechishin OD, Chan JA, Pieper RO, Ronen SM, Weiss S, Luchman HA, Cairncross JG. PMID: 24366912; PMCID: PMC3984548.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansAnimalsCells
    34. Early Chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damage. PLoS One. 2013; 8(5):e62351. Ito M, Ohba S, Gaensler K, Ronen SM, Mukherjee J, Pieper RO. PMID: 23667469; PMCID: PMC3646831.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    35. Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma. PLoS One. 2013; 8(2):e57610. Mukherjee J, Phillips JJ, Zheng S, Wiencke J, Ronen SM, Pieper RO. PMID: 23451252; PMCID: PMC3581484.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    36. Non-invasive in vivo assessment of IDH1 mutational status in glioma. Nat Commun. 2013; 4:2429. Chaumeil MM, Larson PE, Yoshihara HA, Danforth OM, Vigneron DB, Nelson SJ, Pieper RO, Phillips JJ, Ronen SM. PMID: 24019001; PMCID: PMC3908661.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansAnimalsCells
    37. Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging. Magn Reson Med. 2013 Jul; 70(1):33-9. Park I, Hu S, Bok R, Ozawa T, Ito M, Mukherjee J, Phillips JJ, James CD, Pieper RO, Ronen SM, Vigneron DB, Nelson SJ. PMID: 22851374; PMCID: PMC3630274.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    38. Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla. Neuro Oncol. 2012 Aug; 14(8):1050-61. Chaumeil MM, Gini B, Yang H, Iwanami A, Sukumar S, Ozawa T, Pieper RO, Mischel PS, James CD, Berger MS, Ronen SM. PMID: 22670012; PMCID: PMC3408258.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    39. Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency. Cancer Res. 2012 Jul 01; 72(13):3350-9. See WL, Tan IL, Mukherjee J, Nicolaides T, Pieper RO. PMID: 22573716; PMCID: PMC4128256.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    40. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Neuro Oncol. 2011 Dec; 13(12):1331-8. Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, Vandenberg S, Parvataneni R, Nicole A, Sneed PK, Clarke J, Hsieh E, Costa BM, Reis RM, Hristova-Kazmierski M, Nicol SJ, Thornton DE, Prados MD. PMID: 21896554; PMCID: PMC3223090.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCellsCTClinical Trials
    41. NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas. Am J Pathol. 2011 Jul; 179(1):462-76. Moreira F, Kiehl TR, So K, Ajeawung NF, Honculada C, Gould P, Pieper RO, Kamnasaran D. PMID: 21703424; PMCID: PMC3123785.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    42. Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity. PLoS One. 2011; 6(5):e19629. Wang D, Olman MA, Stewart J, Tipps R, Huang P, Sanders PW, Toline E, Prayson RA, Lee J, Weil RJ, Palmer CA, Gillespie GY, Liu WM, Pieper RO, Guan JL, Gladson CL. PMID: 21602932; PMCID: PMC3094350.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    43. Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. Cancer Res. 2011 Jan 01; 71(1):106-15. Nakamura JL, Phong C, Pinarbasi E, Kogan SC, Vandenberg S, Horvai AE, Faddegon BA, Fiedler D, Shokat K, Houseman BT, Chao R, Pieper RO, Shannon K. PMID: 21199799; PMCID: PMC3077533.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    44. Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma. J Clin Neurosci. 2010 Dec; 17(12):1543-7. Waldron JS, Yang I, Han S, Tihan T, Sughrue ME, Mills SA, Pieper RO, Parsa AT. PMID: 20822910; PMCID: PMC3795509.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    45. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res. 2010 Jun 15; 70(12):5046-53. Panner A, Crane CA, Weng C, Feletti A, Fang S, Parsa AT, Pieper RO. PMID: 20484045; PMCID: PMC2891229.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    46. FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes. Cancer Res. 2010 Apr 01; 70(7):2951-61. Dai B, Pieper RO, Li D, Wei P, Liu M, Woo SY, Aldape KD, Sawaya R, Xie K, Huang S. PMID: 20332230; PMCID: PMC2848915.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    47. Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion. Neuroreport. 2009 Dec 09; 20(18):1597-602. Han SJ, Ahn BJ, Waldron JS, Yang I, Fang S, Crane CA, Pieper RO, Parsa AT. PMID: 19875977; PMCID: PMC3666317.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    48. A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res. 2009 Oct 15; 69(20):7911-6. Panner A, Crane CA, Weng C, Feletti A, Parsa AT, Pieper RO. PMID: 19808964; PMCID: PMC3229302.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    49. Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. J Immunother. 2009 Jul-Aug; 32(6):585-92. Crane C, Panner A, Pieper RO, Arbiser J, Parsa AT. PMID: 19483651; PMCID: PMC3795513.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    50. The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res. 2009 Apr 01; 69(7):2809-16. Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA, Zhao D, Bachoo RM, Pieper RO, Habib AA. PMID: 19339267; PMCID: PMC2859885.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansAnimalsCells
    51. p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts. Cancer Res. 2008 Dec 15; 68(24):10034-9. Dinca EB, Lu KV, Sarkaria JN, Pieper RO, Prados MD, Haas-Kogan DA, Vandenberg SR, Berger MS, James CD. PMID: 19074867; PMCID: PMC2987557.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    52. PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Oncogene. 2009 Jan 15; 28(2):306-12. Crane CA, Panner A, Murray JC, Wilson SP, Xu H, Chen L, Simko JP, Waldman FM, Pieper RO, Parsa AT. PMID: 18850006; PMCID: PMC3786571.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCells
    53. S6K1 plays a key role in glial transformation. Cancer Res. 2008 Aug 15; 68(16):6516-23. Nakamura JL, Garcia E, Pieper RO. PMID: 18701474; PMCID: PMC2538583.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    54. H-Ras increases urokinase expression and cell invasion in genetically modified human astrocytes through Ras/Raf/MEK signaling pathway. Glia. 2008 Jun; 56(8):917-24. Zhao Y, Xiao A, Dipierro CG, Abdel-Fattah R, Amos S, Redpath GT, Carpenter JE, Pieper RO, Hussaini IM. PMID: 18383343; PMCID: PMC2408768.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    55. Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. Neoplasia. 2008 Jun; 10(6):604-12. Baia GS, Stifani S, Kimura ET, McDermott MW, Pieper RO, Lal A. PMID: 18516297; PMCID: PMC2386545.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    56. Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN. Laboratory investigation. J Neurosurg. 2008 Feb; 108(2):299-303. Chi JH, Panner A, Cachola K, Crane CA, Murray J, Pieper RO, James CD, Parsa AT. PMID: 18240926.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    57. Glioma invasiveness responds variably to irradiation in a co-culture model. Int J Radiat Oncol Biol Phys. 2007 Nov 01; 69(3):880-6. Nakamura JL, Haas-Kogan DA, Pieper RO. PMID: 17889268.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    58. Heat shock protein 90alpha recruits FLIPS to the death-inducing signaling complex and contributes to TRAIL resistance in human glioma. Cancer Res. 2007 Oct 01; 67(19):9482-9. Panner A, Murray JC, Berger MS, Pieper RO. PMID: 17909058.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    59. Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness. J Neurooncol. 2007 Dec; 85(3):271-80. Cobbs CS, Soroceanu L, Denham S, Zhang W, Britt WJ, Pieper R, Kraus MH. PMID: 17589804.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    60. Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg. 2007 Mar; 106(3):417-27. Kanamori M, Kawaguchi T, Nigro JM, Feuerstein BG, Berger MS, Miele L, Pieper RO. PMID: 17367064.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansCells
    61. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med. 2007 Jan; 13(1):84-8. Parsa AT, Waldron JS, Panner A, Crane CA, Parney IF, Barry JJ, Cachola KE, Murray JC, Tihan T, Jensen MC, Mischel PS, Stokoe D, Pieper RO. PMID: 17159987.
      View in: PubMed   Mentions: 703     Fields:    Translation:HumansCells
    62. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo. Cancer Res. 2006 Dec 01; 66(23):11331-40. Kawaguchi T, Yamashita Y, Kanamori M, Endersby R, Bankiewicz KS, Baker SJ, Bergers G, Pieper RO. PMID: 17145879.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    63. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med. 2006 Dec; 3(12):e485. Lee JC, Vivanco I, Beroukhim R, Huang JH, Feng WL, DeBiasi RM, Yoshimoto K, King JC, Nghiemphu P, Yuza Y, Xu Q, Greulich H, Thomas RK, Paez JG, Peck TC, Linhart DJ, Glatt KA, Getz G, Onofrio R, Ziaugra L, Levine RL, Gabriel S, Kawaguchi T, O'Neill K, Khan H, Liau LM, Nelson SF, Rao PN, Mischel P, Pieper RO, Cloughesy T, Leahy DJ, Sellers WR, Sawyers CL, Meyerson M, Mellinghoff IK. PMID: 17177598; PMCID: PMC1702556.
      View in: PubMed   Mentions: 166     Fields:    Translation:HumansAnimalsCells
    64. The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity. Mol Cancer Ther. 2006 Nov; 5(11):2757-66. Mirzoeva OK, Kawaguchi T, Pieper RO. PMID: 17121922.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    65. Intracranial microenvironment reveals independent opposing functions of host alphaVbeta3 expression on glioma growth and angiogenesis. J Biol Chem. 2006 Dec 01; 281(48):37256-64. Kanamori M, Kawaguchi T, Berger MS, Pieper RO. PMID: 17028191.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    66. Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme. Expert Rev Anticancer Ther. 2006 Sep; 6(9):1313-22. Panner A, Parsa AT, Pieper RO. PMID: 17020463.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    67. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 2007 Mar; 14(3):548-58. Katayama M, Kawaguchi T, Berger MS, Pieper RO. PMID: 16946731.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansCells
    68. mTOR-independent translational control of the extrinsic cell death pathway by RalA. Mol Cell Biol. 2006 Oct; 26(20):7345-57. Panner A, Nakamura JL, Parsa AT, Rodriguez-Viciana P, Berger MS, Stokoe D, Pieper RO. PMID: 16894031; PMCID: PMC1636864.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    69. Translational regulation of TRAIL sensitivity. Cell Cycle. 2006 Jan; 5(2):147-50. Panner A, Parsa AT, Pieper RO. PMID: 16397410.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    70. mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol. 2005 Oct; 25(20):8809-23. Panner A, James CD, Berger MS, Pieper RO. PMID: 16199861; PMCID: PMC1265779.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    71. Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence. Cancer Res. 2005 Jun 01; 65(11):4861-9. Hirose Y, Katayama M, Mirzoeva OK, Berger MS, Pieper RO. PMID: 15930307.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    72. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res. 2005 Feb 15; 65(4):1406-13. Rong Y, Post DE, Pieper RO, Durden DL, Van Meir EG, Brat DJ. PMID: 15735028.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    73. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas. J Neurooncol. 2005 Feb; 71(3):215-22. Nakamura JL, Karlsson A, Arvold ND, Gottschalk AR, Pieper RO, Stokoe D, Haas-Kogan DA. PMID: 15735908.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    74. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer Res. 2004 Oct 01; 64(19):6858-62. Saito R, Bringas JR, Panner A, Tamas M, Pieper RO, Berger MS, Bankiewicz KS. PMID: 15466173.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    75. Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide. J Neurosurg. 2004 Jun; 100(6):1060-5. Hirose Y, Katayama M, Berger MS, Pieper RO. PMID: 15200121.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    76. Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme. Cancer Res. 2004 Apr 15; 64(8):2751-8. Kanamori M, Vanden Berg SR, Bergers G, Berger MS, Pieper RO. PMID: 15087390.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    77. The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents. Mol Cell Biol. 2003 Nov; 23(22):8306-15. Hirose Y, Katayama M, Stokoe D, Haas-Kogan DA, Berger MS, Pieper RO. PMID: 14585987; PMCID: PMC262371.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    78. Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis. Cancer Res. 2003 Apr 15; 63(8):1962-8. Sonoda Y, Kanamori M, Deen DF, Cheng SY, Berger MS, Pieper RO. PMID: 12702589.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    79. Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity. J Neurosurg. 2003 Mar; 98(3):591-8. Hirose Y, Kreklau EL, Erickson LC, Berger MS, Pieper RO. PMID: 12650433.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    80. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res. 2001 Sep 15; 61(18):6674-8. Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO. PMID: 11559533.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimalsCells
    81. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res. 2001 Jul 01; 61(13):4956-60. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS, Pieper RO. PMID: 11431323.
      View in: PubMed   Mentions: 140     Fields:    Translation:HumansAnimalsCells
    82. Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation. J Biol Chem. 2001 Jun 01; 276(22):18871-7. Fanton CP, McMahon M, Pieper RO. PMID: 11278920.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    83. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res. 2001 Mar 01; 61(5):1957-63. Hirose Y, Berger MS, Pieper RO. PMID: 11280752.
      View in: PubMed   Mentions: 152     Fields:    Translation:HumansCells
    84. Highly efficient cell-mediated gene transfer using non-viral vectors and FuGene6: in vitro and in vivo studies. Cell Mol Life Sci. 2000 Aug; 57(8-9):1326-33. Hellgren I, Drvota V, Pieper R, Enoksson S, Blomberg P, Islam KB, Sylvén C. PMID: 11028922.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    85. Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, and glioma cells. Neuro Oncol. 2000 07; 2(3):174-83. Chang GH, Barbaro NM, Pieper RO. PMID: 11302338; PMCID: PMC1920494.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    86. Presetting of chromatin structure and transcription factor binding poise the human GADD45 gene for rapid transcriptional up-regulation. Nucleic Acids Res. 1999 Oct 01; 27(19):3881-90. Graunke DM, Fornace AJ, Pieper RO. PMID: 10481028; PMCID: PMC148652.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    87. Confluence-induced alterations in CpG island methylation in cultured normal human fibroblasts. Nucleic Acids Res. 1999 Aug 01; 27(15):3229-35. Pieper RO, Lester KA, Fanton CP. PMID: 10454622; PMCID: PMC148552.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    88. Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning. Mol Cell Biol. 1997 Oct; 17(10):5813-22. Patel SA, Graunke DM, Pieper RO. PMID: 9315639; PMCID: PMC232429.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    89. Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol. 1997 Sep; 17(9):5612-9. Watts GS, Pieper RO, Costello JF, Peng YM, Dalton WS, Futscher BW. PMID: 9271436; PMCID: PMC232409.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    90. Understanding and manipulating O6-methylguanine-DNA methyltransferase expression. Pharmacol Ther. 1997; 74(3):285-97. Pieper RO. PMID: 9352585.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    91. Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene. J Biol Chem. 1996 Jun 07; 271(23):13916-24. Pieper RO, Patel S, Ting SA, Futscher BW, Costello JF. PMID: 8662860.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    92. In vitro transcription termination by N,N'-bis(2-chloroethyl)-N-nitrosourea-induced DNA lesions. Mol Pharmacol. 1995 Feb; 47(2):290-5. Pieper RO, Noftz SL, Erickson LC. PMID: 7870037.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    93. Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol Cell Biol. 1994 Oct; 14(10):6515-21. Costello JF, Futscher BW, Kroes RA, Pieper RO. PMID: 7523853; PMCID: PMC359181.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    94. The role of two conserved amino acids, glutamine 90 and asparagine 137, in O6-methylguanine-DNA methyltransferase stability, activity and substrate specificity. Carcinogenesis. 1994 Sep; 15(9):1895-902. Pieper RO, Morgan SE, Kelley MR. PMID: 7923583.
      View in: PubMed   Mentions: 4     Fields:    Translation:Cells
    95. Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J Biol Chem. 1994 Jun 24; 269(25):17228-37. Costello JF, Futscher BW, Tano K, Graunke DM, Pieper RO. PMID: 8006031.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    96. The role of the carboxyl-terminal tail in human O6-methylguanine DNA methyltransferase substrate specificity and temperature sensitivity. J Biol Chem. 1993 Sep 15; 268(26):19802-9. Morgan SE, Kelley MR, Pieper RO. PMID: 8366118.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    97. Gene-specific DNA interstrand cross-links produced by nitrogen mustard in the human tumor cell line Colo320HSR. Cell Growth Differ. 1992 Apr; 3(4):217-23. Futscher BW, Pieper RO, Dalton WS, Erickson LC. PMID: 1515367.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    98. DNA-damaging and transcription-terminating lesions induced by AF64A in vitro. J Neurochem. 1992 Apr; 58(4):1504-9. Futscher BW, Pieper RO, Barnes DM, Hanin I, Erickson LC. PMID: 1548483.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    99. Expression of ribosomal phosphoprotein PO is induced by antitumor agents and increased in Mer- human tumor cell lines. Carcinogenesis. 1992 Feb; 13(2):259-63. Grabowski DT, Pieper RO, Futscher BW, Deutsch WA, Erickson LC, Kelley MR. PMID: 1740017.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    100. Direct correlation between methylation status and expression of the human O-6-methylguanine DNA methyltransferase gene. Cancer Commun. 1991 Aug; 3(8):241-53. Pieper RO, Costello JF, Kroes RA, Futscher BW, Marathi U, Erickson LC. PMID: 1716139.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    101. Effects of streptozotocin/bis-chloroethylnitrosourea combination therapy on O6-methylguanine DNA methyltransferase activity and mRNA levels in HT-29 cells in vitro. Cancer Res. 1991 Mar 15; 51(6):1581-5. Pieper RO, Futscher BW, Dong Q, Erickson LC. PMID: 1825618.
      View in: PubMed   Mentions: 7     Fields:    Translation:Cells
    102. DNA adenine adducts induced by nitrogen mustards and their role in transcription termination in vitro. Carcinogenesis. 1990 Oct; 11(10):1739-46. Pieper RO, Erickson LC. PMID: 2208589.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    103. Comparison of O-6-methylguanine DNA methyltransferase (MGMT) mRNA levels in Mer+ and Mer- human tumor cell lines containing the MGMT gene by the polymerase chain reaction technique. Cancer Commun. 1990; 2(1):13-20. Pieper RO, Futscher BW, Dong Q, Ellis TM, Erickson LC. PMID: 2369549.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    104. Transcription-terminating lesions induced by bifunctional alkylating agents in vitro. Carcinogenesis. 1989 Jul; 10(7):1307-14. Pieper RO, Futscher BW, Erickson LC. PMID: 2736721.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    105. Interrelationship of 3-deazaguanine-induced growth inhibitory actions in L1210 cells. Biochem Pharmacol. 1988 Sep 15; 37(18):3534-7. Pieper RO, Mandel HG. PMID: 3422001.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    106. DNA-directed actions of 3-deazaguanine: effects on DNA integrity and DNA elongation/ligation. Cancer Res. 1988 May 15; 48(10):2774-8. Pieper RO, Kennedy KA, Mandel HG. PMID: 3359439.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    107. Correlation of biochemical effects and incorporation of 3-deazaguanine into nucleic acids to cytotoxicity in L1210 cells. Cancer Res. 1986 Oct; 46(10):4960-5. Pieper RO, Barrows LR, Mandel HG. PMID: 3756857.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    108. Gastric cancer. Factors influencing longterm survival and postoperative mortality. Acta Chir Scand Suppl. 1986; 530:25-9. Sjöstedt S, Pieper R. PMID: 2425528.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Russell's Networks
    Concepts (504)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (51)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.